Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Journal of Market Access & Health Policy
|
October 27, 2025
Vaccine Development, Its Implementation and Price Setting: A Historical Perspective with Proposed Ways to Move Forward
Baudouin Standaert, Oleksandr Topachevskyi, Olivier Ethgen
BMC Health Services Research
|
November 10, 2012
Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model
Mustafa Bakır, Ozden Türel, Oleksandr Topachevskyi
Pharmacoeconomics
|
July 14, 2012
The impact of rotavirus vaccination on discounted net tax revenue in Egypt: a government perspective analysis
Mark P Connolly, Oleksandr Topachevskyi, Baudouin Standaert, et al.
Health Policy (Amsterdam, Netherlands)
|
October 29, 2017
Optimising the introduction of multiple childhood vaccines in Japan: A model proposing the introduction sequence achieving the highest health gains
Baudouin Standaert, Nadia Schecroun, Olivier Ethgen, et al.
Value in Health Regional Issues
|
April 29, 2018
The Health Economic Impact of Universal Infant Vaccination with the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine as Compared with 13-Valent Pneumococcal Conjugate Vaccine in Hong Kong
Kenneth K C Lee, David Bin Chia Wu, Oleksandr Topachevskyi, et al.
BMC Public Health
|
November 1, 2013
Cost-effectiveness and cost utility analysis of three pneumococcal conjugate vaccines in children of Peru
Jorge Alberto Gomez, Juan Carlos Tirado, Aldo Amador Navarro Rojas, et al.
Value in Health Regional Issues
|
April 29, 2018
Cost-Effectiveness Analysis of Pneumococcal Vaccination with the Pneumococcal Polysaccharide NTHi Protein D Conjugate Vaccine in the Philippines
Xu-Hao Zhang, Maria Carmen Nievera, Josefina Carlos, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Journal of Market Access & Health Policy
|
October 27, 2025
Vaccine Development, Its Implementation and Price Setting: A Historical Perspective with Proposed Ways to Move Forward
Baudouin Standaert, Oleksandr Topachevskyi, Olivier Ethgen
BMC Health Services Research
|
November 10, 2012
Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model
Mustafa Bakır, Ozden Türel, Oleksandr Topachevskyi
Pharmacoeconomics
|
July 14, 2012
The impact of rotavirus vaccination on discounted net tax revenue in Egypt: a government perspective analysis
Mark P Connolly, Oleksandr Topachevskyi, Baudouin Standaert, et al.
Health Policy (Amsterdam, Netherlands)
|
October 29, 2017
Optimising the introduction of multiple childhood vaccines in Japan: A model proposing the introduction sequence achieving the highest health gains
Baudouin Standaert, Nadia Schecroun, Olivier Ethgen, et al.
Value in Health Regional Issues
|
April 29, 2018
The Health Economic Impact of Universal Infant Vaccination with the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine as Compared with 13-Valent Pneumococcal Conjugate Vaccine in Hong Kong
Kenneth K C Lee, David Bin Chia Wu, Oleksandr Topachevskyi, et al.
BMC Public Health
|
November 1, 2013
Cost-effectiveness and cost utility analysis of three pneumococcal conjugate vaccines in children of Peru
Jorge Alberto Gomez, Juan Carlos Tirado, Aldo Amador Navarro Rojas, et al.
Value in Health Regional Issues
|
April 29, 2018
Cost-Effectiveness Analysis of Pneumococcal Vaccination with the Pneumococcal Polysaccharide NTHi Protein D Conjugate Vaccine in the Philippines
Xu-Hao Zhang, Maria Carmen Nievera, Josefina Carlos, et al.
Page
of 1